Insulin Resistance Intervention After Stroke Trial
Diseases and Conditions Researched
Diabetes; Myocardial Infarction; Stroke
What is the purpose of this trial?
The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.
Click here for detailed participation information for this trial.
|Sponsors:||National Institute of Neurological Disorders and Stroke (NINDS); Takeda Pharmaceuticals North America, Inc.; Yale University|
|Dates:||September 20, 2004|
|Last Updated:||August 3, 2011|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.